ANI Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ANIP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Aug 26	SellUS$243,474	Ori Gutwerg	Individual	3,162	US$77.00
13 May 26	SellUS$1,127,120	Patrick Walsh	Individual	13,973	US$80.75
12 May 26	SellUS$36,357	Thomas Rowland	Individual	459	US$79.21
12 May 26	SellUS$220,374	Ori Gutwerg	Individual	2,772	US$79.50
11 May 26	SellUS$4,266,350	Nikhil Lalwani	Individual	55,000	US$77.57
11 Mar 26	SellUS$357,471	Thomas Rowland	Individual	4,772	US$74.91
05 Mar 26	SellUS$302,240	Stephen Carey	Individual	4,000	US$75.56
03 Mar 26	SellUS$445,380	Patrick Walsh	Individual	6,000	US$74.23
03 Mar 26	SellUS$157,590	Ori Gutwerg	Individual	2,060	US$76.50
05 Dec 25	SellUS$146,070	Renee Tannenbaum	Individual	1,800	US$81.15
13 Nov 25	SellUS$750,904	Patrick Walsh	Individual	8,643	US$86.88
13 Nov 25	SellUS$8,272	Chad Gassert	Individual	94	US$88.00
12 Nov 25	SellUS$1,304,163	Chad Gassert	Individual	14,642	US$89.07

Insider Trading Volume

Insider Buying: ANIP insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANIP?
Owner Type	Number of Shares	Ownership Percentage
State or Government	7,063	0.0267%
Private Companies	436,920	1.65%
Individual Insiders	1,327,469	5.03%
Institutions	24,640,915	93.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.09% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.8%	BlackRock, Inc.	2,958,646	US$225.3m	7.69%	no data
4.73%	MVP Capital Partners	1,014,381	US$77.2m	0%	100.0%
4.53%	Vanguard Capital Management, LLC	971,811	US$74.0m	2.27%	no data
4.05%	Soleus Capital Management, L.P.	867,760	US$66.1m	5.79%	2.31%
3.88%	State Street Investment Management	831,647	US$63.3m	7.78%	no data
3.3%	Tang Capital Management, LLC	707,500	US$53.9m	0%	2.37%
2.91%	Dimensional Fund Advisors LP	623,463	US$47.5m	17.4%	0.01%
2.68%	American Century Investment Management Inc	574,474	US$43.7m	200%	0.01%
2.62%	Arrowstreet Capital, Limited Partnership	562,016	US$42.8m	-0.42%	0.02%
2.6%	Global Alpha Capital Management Ltd.	558,003	US$42.5m	54.5%	1.25%
2.5%	Geode Capital Management, LLC	536,407	US$40.8m	9.65%	no data
2.37%	Millennium Management LLC	507,207	US$38.6m	-14.3%	0.02%
2.02%	Esjay Llc	431,920	US$32.9m	0%	no data
1.9%	Vanguard Portfolio Management, LLC	407,281	US$31.0m	8.33%	no data
1.6%	Ranger Investment Management, L.P.	343,150	US$26.1m	-4.7%	1.87%
1.59%	UBS Asset Management AG	339,818	US$25.9m	-35.9%	no data
1.58%	Nikhil Lalwani	339,089	US$25.8m	-3.09%	no data
1.38%	Kennedy Capital Management LLC	295,938	US$22.5m	0.66%	0.43%
1.37%	Invesco Capital Management LLC	293,504	US$22.3m	-4.79%	no data
1.34%	Columbia Management Investment Advisers, LLC	287,382	US$21.9m	6.33%	no data
1.34%	Nomura Investment Management Business Trust	287,206	US$21.9m	-0.12%	0.03%
1.27%	Ikarian Capital, LLC	272,085	US$20.7m	85%	4.05%
1.27%	Aberdeen Group Plc	271,760	US$20.7m	31.8%	0.01%
1.24%	Oberweis Asset Management, Inc.	265,306	US$20.2m	19.8%	0.41%
1.2%	William Blair Investment Management, LLC	258,173	US$19.7m	-21.1%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/21 07:54
End of Day Share Price	2026/09/18 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ANI Pharmaceuticals, Inc. is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Glen Santangelo	Barclays
Gary Nachman	Canaccord Genuity
Dewey Steadman	Canaccord Genuity